RetractedArticleJournal of healthcare engineering2022

FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer.

Lan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.